IHL 0.00% 4.1¢ incannex healthcare limited

Ann: Options Exercise, page-12

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 95 Posts.
    lightbulb Created with Sketch. 84
    Combination In Vitro results of ARDS trial is due about same time as oppies expiry, being that will be 4 weeks post previous results ann which is the timeline given on Incannex website. I'd be surprised if they released results before tails are done but they will be very close IMO.

    Given we have not seen any OSA update I would assume this has fallen into the next phase of ethics committee approvals. So as long as it is approved at the next meeting on the 24th (also lines up with oppies final trading timeline) I would expect some positive news not too long after. I think there are quite a few players waiting on this one in paricular.

    Follow these up with potential oil sales update, TBI trial and Qtrly report you have a sold runway of positive news flow we can ride for a long period with no oppies overhang.

    Solid runway to launch into 2021 when I think the magic will really happen

 
watchlist Created with Sketch. Add IHL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.